Federal Rlty Inv Trust (NYSE:FRT), Glimcher Realty Trust (NYSE:GRT), Haynes Intl Inc(NASDAQ:HAYN), Home Properties (NYSE:HME) and Hercules Technology (NASDAQ:HTGC) declare dividends.
The Board of Directors of Federal Rlty Inv Trust (FRT) declared a quarterly common stock dividend of $0.67 a share payable 7/15/11 to shareholders of record at the close of business on 6/23/11.
The Board of Directors of Glimcher Realty Trust (RT) declared a cash dividend of $0.10 a share on the company's common stock payable on 7/15/11 to Stockholders of record on 6/30/11.
The Board of Directors of Haynes Intl Inc (HAYN) declared a regular cash dividend of $0.20 a common share. The dividend will be payable on 6/15/11 to common stockholders of record at the close of business on 6/1/11.
The Board of Directors of Home Properties (HME) declared a regular cash dividend of $0.62 per common share. The dividend will be payable on 5/27/11 to common stockholders of record at the close of business on 5/17/11.
The Board of Directors of Hercules Technology Growth Capital (HTGC) declared a regular cash dividend of $0.22 per common share. The dividend will be payable on 6/23/11 to common stockholders of record at the close of business on 5/13/11.
Showing posts with label Glimcher Realty. Show all posts
Showing posts with label Glimcher Realty. Show all posts
Friday, May 6, 2011
Dividends from (FRT) (GRT) (HAYN) (HME) (HTGC) Declared
Wednesday, April 27, 2011
Medifast (MED) (ATHN) (GRT) LXRX) - New Ratings and Price Targets
New ratings and price targets on Medifast, Inc. (NYSE: MED), AthenaHealth (NASDAQ: ATHN), Glimcher Realty Trust (NYSE: GRT) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).
Oppenheimer initiated coverage on AthenaHealth (ATHN). They placed an “Underperform” rating and a price target of $30.00 on the firm.
Goldman Sachs (NYSE:GS) initiated coverage on Glimcher Realty Trust (GRT). They placed a “Neutral” rating on the stock.
Wedbush initiated coverage on Lexicon Pharmaceuticals, Inc. (LXRX). They placed an “Outperform” rating and a price target of $3.00 on the company.
Capstone initiated coverage on Medifast, Inc. (MED). They placed a “Buy” rating on the shares.
Subscribe to:
Posts (Atom)